Results from the Phase 3 ATTAIN-1 trial in adults with obesity without type 2 diabetes
Clinical trials have demonstrated reductions in HbA1c (a measure of average blood glucose over three months) with semaglutide treatment, with improvements varying based on baseline levels and dose
Key takeaways Common side effects of meloxicam include upper respiratory infections, abdominal pain, diarrhea, indigestion, and flu-like symptoms
The above is the whole content of today
Hair loss is reported more often in female users (about 7%) than male users (under 1%), and is associated with the rate of weight reduction rather than tirzepatide itself
How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals predispositions in GLP-1 receptor, incretin, and appetite regulation pathwaysinformation that may help provide context for microdose versus standard-dose initiation decisions